Craneware plc
("Craneware" or the "Company")
Blocklisting Application
Craneware plc (AIM: CRW.L), the market leader in Value Cycle software solutions for the US healthcare market, announces that a block listing application has been made to the London Stock Exchange for 200,000 ordinary shares of one pence each ("Ordinary Shares") to be admitted to trading on AIM (the "Admission"). The Ordinary Shares that are being reserved under this block listing application will be issued by the Company, as required, in order to satisfy the exercise of share options pursuant to the terms of the following share plans:
|
Share plan |
Number of Ordinary Shares |
|
The Craneware plc SAYE Option Plan (2018) |
100,000 |
|
The Craneware plc Employee Stock Purchase Plan (2018) |
100,000 |
|
|
|
|
Total |
200,000 |
It is expected that Admission of these Ordinary Shares will become effective on 16 February 2022. When issued, the Ordinary Shares will be credited as fully paid and will rank pari passu in all respects with the existing Ordinary Shares.
For further information, please contact:
|
Craneware plc |
+44 (0)131 550 3100 |
|
Keith Neilson, CEO |
|
|
Craig Preston, CFO |
|
|
|
|
|
Alma (Financial PR) |
+44 (0)20 3405 0205 |
|
Caroline Forde, Hilary Buchanan, Joe Pederzolli |
craneware@almapr.co.uk |
|
|
|
|
Peel Hunt (NOMAD and Joint Broker) |
+44 (0)20 7418 8900 |
|
Dan Webster, Andrew Clark, Lalit Bose |
|
|
|
|
|
Investec Bank PLC (Joint Broker) |
+44 (0)20 7597 5970 |
|
Patrick Robb, Henry Reast, Sebastian Lawrence |
|
|
|
|
|
Berenberg (Joint Broker) |
+44 (0)20 3207 7800 |
|
Mark Whitmore, Richard Andrews, Alix Mecklenburg-Solodkoff |
|
About Craneware
We at the Craneware Group of companies, including our latest additions Sentry Data Systems and Agilum Healthcare Intelligence, passionately believe we can impact healthcare profoundly by delivering the insights healthcare organizations need to also transform the business of healthcare. Our shared vision is to be the operational and financial partner for U.S. healthcare providers.
Our combined suite of applications and industry-leading team of experts help our customers contextualize operational, financial, and clinical data, providing insights that clearly demonstrate what great looks like. These value cycle insights deliver revenue integrity and 340B compliance, as well as margin and operational intelligence - something no other single partner can provide.
Together, approximately 40% of registered U.S. hospitals are now our customers, including more than 2000 U.S hospitals and health systems and almost 10,000 clinics and retail pharmacies. Our customers are operating with a financial impact of nearly half a trillion dollars. We have data sets from customers covering more than 150 million unique patients encounters.
Learn more at craneware.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
